Zhang, Bo https://orcid.org/0000-0002-4381-1124
Fong, Youyi
Dang, Lauren
Fintzi, Jonathan
Chen, Shiyu https://orcid.org/0000-0003-2902-0403
Wang, Jing
Rouphael, Nadine G. https://orcid.org/0000-0002-2512-7919
Branche, Angela R. https://orcid.org/0000-0002-7742-5352
Diemert, David J. https://orcid.org/0000-0002-2789-0512
Falsey, Ann R.
Graciaa, Daniel S. https://orcid.org/0000-0002-9484-8488
Baden, Lindsey R. https://orcid.org/0009-0004-1752-1926
Frey, Sharon E.
Whitaker, Jennifer A.
Little, Susan J. https://orcid.org/0000-0002-7645-9737
Kamidani, Satoshi
Walter, Emmanuel B.
Novak, Richard M.
Rupp, Richard https://orcid.org/0000-0002-9659-1217
Jackson, Lisa A.
Yu, Chenchen
Magaret, Craig A. https://orcid.org/0000-0002-5056-2664
Molitor, Cindy
Borate, Bhavesh
Busch, Sydney
Benkeser, David https://orcid.org/0000-0002-1019-8343
Netzl, Antonia https://orcid.org/0000-0001-8034-2382
Smith, Derek J. https://orcid.org/0000-0002-2393-1890
Babu, Tara M.
Kottkamp, Angelica C. https://orcid.org/0000-0003-4103-1666
Luetkemeyer, Anne F. https://orcid.org/0000-0003-0911-1578
Immergluck, Lilly C.
Presti, Rachel M.
Bäcker, Martín
Winokur, Patricia L.
Mahgoub, Siham M.
Goepfert, Paul A. https://orcid.org/0000-0001-8441-5737
Fusco, Dahlene N. https://orcid.org/0000-0002-5629-0110
Atmar, Robert L. https://orcid.org/0000-0001-9989-6772
Posavad, Christine M.
Mu, Jinjian
Makowski, Mat
Makhene, Mamodikoe K.
Nayak, Seema U.
Roberts, Paul C. https://orcid.org/0000-0002-4452-141X
Gilbert, Peter B. https://orcid.org/0000-0002-2662-9427
Follmann, Dean https://orcid.org/0000-0003-4073-0393
,
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (contract 75N910D00024, task order 75N91022F00007)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (contract 75N910D00024, task order no. 75N91022F00007)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (75N93021C00012)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (UM1AI148684)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (75N93021C00014)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R37AI054165)
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (Contract no. 75A50122C00008)
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (75A50122C00008)
U.S. Department of Health & Human Services | Biomedical Advanced Research and Development Authority (75N93021D00021)
Gates Cambridge Trust
Article History
Received: 19 July 2024
Accepted: 5 January 2025
First Online: 17 January 2025
Competing interests
: N.G.R. is a paid safety consultant for ICON, CyanVac, Imunon, and EMMES, and has served on selected advisory boards for Sanofi, Seqirus, Pfizer-BioNTech and Moderna. Emory receives funds for N.G.R. to conduct research from Sanofi, Lilly, Merck, Quidel, Immorna, Vaccine Company, and Pfizer-BioNTech. S.K. reports research support to his institution from Pfizer-BioNTech, Moderna, Bavarian Nordic, Meissa, Centers for Disease Control and Prevention, and National Institutes of Health. E.B.W. has served as an investigator for clinical trials or studies sponsored by Pfizer-BioNTech, Moderna, Seqirus, Najit, and Clinetic; on advisory boards for Pfizer-BioNTech and Vaxcyte; as a consultant to IliAD Biotechnologies; and as a DSMB member for Shionogi. T.M.B. has served on an Advisory Board for Sanofi. D.N.F. has served on an Advisory Board for Gilead Sciences and for AXCELLA, and as site PI for clinical trials sponsored by Gilead Sciences, Regeneron, MetroBiotech LLC, and the NIH (DMID COVAIL). The remaining authors declare no competing interests.